Publicacións nas que colabora con José Benito (14)

2016

  1. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2013

  1. The changing face of hepatitis C in the new era of direct-acting antivirals

    Antiviral Research

  2. Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

    Antiviral Therapy, Vol. 18, Núm. 5, pp. 709-715

2012

  1. Differences in virological response to peginterferon-a plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b

    Journal of Acquired Immune Deficiency Syndromes, Vol. 60, Núm. 2, pp. 117-123

  2. Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

    Journal of Clinical Virology, Vol. 55, Núm. 1, pp. 58-61

2011

  1. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

    HIV Medicine, Vol. 12, Núm. 8, pp. 487-493

  2. Elevated TGF-β1 levels might protect HCV/HIV-coinfected patients from liver fibrosis

    European Journal of Clinical Investigation, Vol. 41, Núm. 1, pp. 70-76

  3. Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV-hepatitis C virus-coinfected patients with prior nonresponse or relapse

    AIDS, Vol. 25, Núm. 8, pp. 1131-1133

  4. Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/Hepatitis C virus-coinfected patients treated for chronic hepatitis C

    Clinical Infectious Diseases, Vol. 53, Núm. 12, pp. 1291-1295

  5. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy

    Journal of Infectious Diseases, Vol. 203, Núm. 11, pp. 1629-1636

2010

  1. Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV

    Clinical Infectious Diseases, Vol. 51, Núm. 10, pp. 1209-1216

2007

  1. Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

    AIDS, Vol. 21, Núm. 5, pp. 583-588

2006

  1. Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine

    AIDS Research and Human Retroviruses, Vol. 22, Núm. 8, pp. 734-743

2004

  1. Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea

    AIDS, Vol. 18, Núm. 9, pp. 1251-1261